|
Description
xMAP technology offers clear advantages over Western blots when studying cell signaling pathways. Using phospho-specific antibodies, xMAP enables multiplexing of up to 100 different antibodies within the same sample well, saving precious sample and labor as compared to single-plex Western blots. The output data are numerical, quantitative and reproducible.
Tests available from:
Bio-Rad
Invitrogen
EMD/Merck (Novagen)
Panomics
Millipore Corporation (LINCO & Upstate)
QIAGEN
|
|
 |
|